- Alle
- Pressemitteilungen
- Empfehlungen
- Chartanalysen
- Berichte
| Zeit | Aktuelle Nachrichten Sprache:
Alle DE EN | Leser | Medien | ||
|---|---|---|---|---|---|
| Do | XFRA NEW INSTRUMENTS AVAILABLE ON 18.06.2026 | 162 | Xetra Newsboard | The following instruments on XETRA do have their first trading 18.06.2026 Die folgenden Instrumente in XETRA haben ihren ersten Handelstag 18.06.2026
Aktien
1 SE0029278985 Tangen Industrikapital... ► Artikel lesen | |
| Mi | XFRA DELETION OF INSTRUMENTS FROM BOERSE FRANKFURT - 17.06.2026 | 331 | Xetra Newsboard | The following instruments on Boerse Frankfurt do have their last trading day on 17.06.2026Die folgenden Instrumente in Boerse Frankfurt haben ihren letzten Handelstag am 17.06.2026ISIN NameCA1202272029 BULLION... ► Artikel lesen | |
| Mi | Bullion Gold Discoveries Corp: Bullion Gold closes $2-million private placement | 1 | Stockwatch | ||
| Mi | XFRA ISIN CHANGE | 167 | Xetra Newsboard | Einstellung Aufnahme ISIN Name Einstellung mit Ablauf: ISIN Name Ab dem: AnmerkungenCA1202272029 Bullion Gold Discoveries Corp. 17.06.2026 CA1199331093 Bullion Gold Discoveries Corp. 18.06.2026 Tausch... ► Artikel lesen | |
| Mi | Bullion Gold Discoveries Corp.: Bullion Closes $2M Private Placement | 319 | Newsfile | Montreal, Quebec--(Newsfile Corp. - June 17, 2026) - Bullion Gold Discoveries Corp. (TSXV: BGD) ("Bullion" or the "Company") is pleased to announce that it has closed its previously announced non-brokered... ► Artikel lesen | |
| Mi | XFRA CAPITAL ADJUSTMENT INFORMATION - 17.06.2026 | 114 | Xetra Newsboard | Das Instrument EA20 NO0013601245 EAM SOLAR AS NK -,10 EQUITY wird cum Kapitalmassnahme gehandelt am 17.06.2026 und ex Kapitalmassnahme am 18.06.2026 The instrument EA20 NO0013601245 EAM SOLAR AS NK... ► Artikel lesen | |
| Di | XFRA B4R: AUSSETZUNG/SUSPENSION | 108 | Xetra Newsboard | DAS/ DIE FOLGENDE(N) INSTRUMENT(E) IST/ SIND AB SOFORT AUSGESETZT:THE FOLLOWING INSTRUMENT(S) IS/ ARE SUSPENDED WITH IMMEDIATE EFFECT:INSTRUMENT NAME KUERZEL/SHORTCODE ISIN BIS/UNTILBULLION GOLD RES... ► Artikel lesen | |
| BULLION GOLD DISCOVERIES Aktie jetzt für 0€ handeln | |||||
| Sa | Bullion Gold Resources Corp (2): Bullion Gold name change to Bullion Gold Discoveries | 6 | Stockwatch | ||
| 12.06. | Bullion Gold Resources Corp. kündigt Namensänderung an | 1 | GoldSeiten.de | ||
| 12.06. | Bullion Gold Resources Corp (2): Bullion Gold Resources to change name | 1 | Stockwatch | ||
| 11.06. | Bullion Gold Resources Corp.: Bullion Announces Name Change to Bullion Gold Discoveries Corp | 494 | Newsfile | Montreal, Quebec--(Newsfile Corp. - June 11, 2026) - Bullion Gold Resources Corp. (TSXV: BGD) ("Bullion" or the "Company") is pleased to announce that it will complete a name change from "Bullion... ► Artikel lesen | |
| 09.06. | Bullion Gold Resources Corp (2): Bullion Gold moves field crew to Terragold | 1 | Stockwatch | ||
| 09.06. | Bullion Gold Resources Corp.: Bullion Mobilizes Field Team to Terragold Project and Increases Private Placement to $2 Million | 341 | Newsfile | Montreal, Quebec--(Newsfile Corp. - June 9, 2026) - Bullion Gold Resources Corp. (TSXV: BGD) ("Bullion" or the "Company") is pleased to announce that its field team has been mobilized to Bullion's... ► Artikel lesen | |
| 02.06. | Bullion Gold Resources Corp (2): Bullion arranges $1.5-million private placement | 2 | Stockwatch | ||
| 02.06. | Bullion Gold Resources Corp.: Bullion Announces $1.5 Million Private Placement | 313 | Newsfile | Montreal, Quebec--(Newsfile Corp. - June 2, 2026) - Bullion Gold Resources Corp. (TSXV: BGD) ("Bullion" or the "Company") is pleased to announce a private placement of up to 16,666,667 units of... ► Artikel lesen | |
| 27.05. | Bullion Gold Resources Corp (2): Bullion Gold optionee to resume drilling at Bousquest | 4 | Stockwatch | ||
| 27.05. | Bullion Gold Resources Corp.: Olympio to Resume Drilling at Bousquet Gold Project, Earns 51% interest | 450 | Newsfile | Montreal, Quebec--(Newsfile Corp. - May 27, 2026) - Bullion Gold Resources Corp. (TSXV: BGD) ("Bullion" or the "Company") is pleased to announce that optionee Olympio Metals Limited (ASX: OLY) ("Olympio")... ► Artikel lesen | |
| 19.05. | Bullion Gold Resources Corp (2): Bullion Gold appoints Britt as technical committee | 2 | Stockwatch | ||
| 13.05. | Bullion Gold Resources Corp (2): Bullion Gold completes Terragold 3-D geological model | 3 | Stockwatch | ||
| 13.05. | Bullion Gold Resources Corp.: BULLION Completes Terragold Historical Compilation and Uploads Leapfrog 3D Geological Model on YouTube | 295 | Newsfile | Montreal, Quebec--(Newsfile Corp. - May 13, 2026) - Bullion Gold Resources Corp. (TSXV: BGD) ("Bullion" or the "Company") is pleased to announce the completion of a comprehensive compilation and... ► Artikel lesen |
1 2 3 Weiter >>
60 Nachrichten in den letzten 12 Monaten
| Unternehmen / Aktien | Aktienkurs | % | Top-Nachrichten | ||
|---|---|---|---|---|---|
| APOGEE THERAPEUTICS | 90,38 | 0,00 % | Apogee Therapeutics, Inc. - 8-K, Current Report | ||
| ERASCA | 13,670 | 0,00 % | Erasca, Inc.: Erasca Reports First Quarter 2026 Business Updates and Financial Results | Robust monotherapy efficacy and generally well-tolerated safety results observed during dose escalation for ERAS-0015 in both KRAS G12X NSCLC and PDAC reinforce best-in-class potential across RAS-targeted... ► Artikel lesen | |
| SOLID BIOSCIENCES | 8,330 | 0,00 % | Solid Biosciences Inc.: Solid Biosciences Reports First Quarter 2026 Financial Results and Provides Business Updates | - Duchenne (SGT-003): First participant dosed in the Phase 3 IMPACT DUCHENNE clinical trial, receipt of positive opinion on the Company's Pediatric Investigation Plan from the European Medicines... ► Artikel lesen | |
| RECURSION PHARMACEUTICALS | 3,230 | 0,00 % | Hauptversammlung von Recursion Pharmaceuticals: Aktionäre stimmen allen Vorschlägen zu | ||
| MAPLIGHT THERAPEUTICS | 28,820 | 0,00 % | MapLight Therapeutics, Inc. - 8-K, Current Report | ||
| TANGO THERAPEUTICS | 27,870 | -0,36 % | Tango Therapeutics auf Rekordhoch: Aktie steigt auf 33,19 USD | ||
| TAYSHA GENE THERAPIES | 6,420 | 0,00 % | Taysha Gene Therapies, Inc.: Taysha Gene Therapies Reports First Quarter 2026 Financial Results and Provides Corporate Update | Reaffirmed FDA alignment on TSHA-102 BLA pathway, including pivotal trial design, endpoints and potential to submit for approval based on REVEAL pivotal trial 6-month interim analysis, following... ► Artikel lesen | |
| ANNEXON | 4,900 | 0,00 % | Annexon Biosciences: Annexon Reports Inducement Grants to New Employees Under Nasdaq Listing Rule 5635(c)(4) | ||
| ODYSSEY THERAPEUTICS | 19,070 | 0,00 % | Odyssey Therapeutics Inc: Odyssey Therapeutics Reports First Quarter 2026 Financial Results and Provides Corporate Update | Reported positive clinical proof-of-concept data for OD-001, our first-in-class, oral RIPK2 scaffolding inhibitor, in a Phase 2a monotherapy trial for moderate to severe ulcerative colitis Cash on... ► Artikel lesen | |
| OLEMA PHARMACEUTICALS | 9,510 | 0,00 % | How Olema Pharmaceuticals (OLMA) Is Adding Pipeline Depth Behind Its Palazestrant Breast Cancer Bet | ||
| PRAXIS PRECISION MEDICINES | 282,15 | -0,06 % | Praxis Precision Medicines, Inc. - 8-K, Current Report | ||
| SANA BIOTECHNOLOGY | 3,150 | 0,00 % | Sana Biotechnology, Inc: Sana Biotechnology Announces Sale of Approximately $69 Million of Shares Through its At-the-Market (ATM) Facility | SEATTLE, May 15, 2026 (GLOBE NEWSWIRE) -- Sana Biotechnology, Inc. (NASDAQ: SANA), a company focused on changing the possible for patients through engineered cells, today announced that it has sold... ► Artikel lesen | |
| BRIDGEBIO ONCOLOGY THERAPEUTICS | 7,560 | 0,00 % | BridgeBio Oncology Therapeutics, Inc.: BBOT Reports First Quarter 2026 Financial Results and Update on Corporate Progress | Announced encouraging preliminary safety and efficacy data across all three RAS-pathway inhibitor programsAnnounced publication in Cancer Discovery highlighting preclinical data demonstrating BBO-11818... ► Artikel lesen | |
| COGENT BIOSCIENCES | 34,520 | -0,06 % | Cogent Biosciences, Inc.: Cogent Biosciences Announces Preclinical Data from Novel JAK2 V617F Inhibitor at the 2026 European Hematology Association (EHA) Congress | - JAK2 V671F poster presentation showcases potential best-in-class properties, including improved selectivity compared with currently approved JAK inhibitors - - Selective JAK V617F inhibitor, CGT1145... ► Artikel lesen | |
| KYMERA THERAPEUTICS | 90,43 | 0,00 % | Kymera presents KT-621 phase 1 data in Japanese adults |
Das Unternehmen BULLION GOLD DISCOVERIES CORPORATION kann der Branche Biotechnologie zugeordnet werden. Mit einer aktuellen Kursveränderung von +0,000 (+0,71 %) liegt der Kurs bei 0,043 Euro.
VerkaufenHaltenKaufen
■ Verkaufen
■ Halten
■ Kaufen
Sie erhalten auf FinanzNachrichten.de kostenlose Realtime-Aktienkurse von und sowie Kurse und Daten von ARIVA.DE AG.
Weitere Kennzahlen, Fundamentaldaten und Unternehmensinformationen zu BULLION GOLD DISCOVERIES CORPORATION finden Sie auf Wallstreet Online.